News

Juvenescence is pleased to announce the close of the first tranche of its Series B financing, in the amount of $46 million. Juvenescence intends to complete its $100 million Series B financing with the closing of a second tranche in…...

Juvenescence, The Buck Institute for Research on Aging, and Insilico Medicine announced today that they have formed Napa Therapeutics, Ltd to develop drugs against a novel aging-related target. The Buck Institute is one of the leading research centers in the…...

Juvenescence has successfully raised $50 million in its Series A financing. The Series A financing was oversubscribed with participation from founders, insiders, institutional investors and family offices. Jim Mellon, of Juvenescence Limited said: “We are delighted with the progress we…...

Juvenescence announced the appointment of Karim Hakimzadeh to its Board of Directors. The appointment increases the size of the Board of Directors to five members. “It’s a great privilege to serve on the board of a company in one of…...

Juvenescence announced that it has closed its seed funding round, raising USD $12.3 million. The Seed Round was significantly oversubscribed and included undisclosed sums from a range of seasoned international angel investors and institutions, including Foresite Capital, Karim Hakimzadeh, Andrew…...

  • 1
  • 2